Abstract: A composition suitable for topical application comprising a continuous phase and at least one discontinuous phase, said composition comprising at least one polyaphron dispersion, at least one vitamin D or vitamin D analogue and at least one corticosteroid.
Type:
Application
Filed:
February 27, 2019
Publication date:
November 28, 2019
Applicant:
DRUG DELIVERY SOLUTIONS LIMITED
Inventors:
Derek WHEELER, David F. Steele, Michelle Georgiou, Steen Sindet-Pedersen
Abstract: A composition suitable for topical application comprising a continuous phase and at least one discontinuous phase, said composition comprising at least one polyaphron dispersion, at least one vitamin D or vitamin D analog and at least one corticosteroid.
Type:
Grant
Filed:
March 14, 2008
Date of Patent:
April 23, 2019
Assignee:
DRUG DELIVERY SOLUTIONS LIMITED
Inventors:
Derek Wheeler, David F. Steele, Michelle Georgiou, Steen Sindet-Pedersen
Abstract: A bioerodible patch comprising at least one bioadhesive layer and at least one non-bioadhesive layer, wherein the bioadhesive layer comprises at least one polyaphron dispersion and at least one bioadhesive polymer, and wherein the polyaphron dispersion comprises at least one pharmaceutically active agent.
Type:
Grant
Filed:
June 26, 2008
Date of Patent:
January 24, 2017
Assignee:
DRUG DELIVERY SOLUTIONS LIMITED
Inventors:
Nigel Crutchley, Steen Sindet-Pedersen, Stephen Lenon
Abstract: A biliquid foam includes from 10% to 98% by weight of a non-polar liquid other than a fuel and from 2 to 88% by weight of a continuous phase polar liquid comprising a C1-C4 alcohol, a liquid polyethylene glycol, ethylene glycol or propylene glycol, or mixtures thereof, in an amount of at least 65% by weight, relative to the weight of the continuous phase, wherein the biliquid foam is stabilized with an amount of from 0.05% to 2% by weight based on the total formulation of a surfactant which is selected from castor oil/poly(alkylene glycol) adducts containing from 20 to 50 alkoxy groups, a C8-C24 fatty acid or hydrogenated castor oil/poly(alkylene glycol) adducts containing from 20 to 60 alkoxy groups, or mixtures thereof.
Type:
Grant
Filed:
July 30, 2004
Date of Patent:
December 10, 2013
Assignee:
Drug Delivery Solutions Limited
Inventors:
Monica Dias, Philip Guffogg, Derek Wheeler, Mark Whitbread-Jordan
Abstract: A discrete powder which includes particles in which a biliquid foam has been entrapped within a matrix of a polymeric material. A process for the preparation of these discrete powders includes the steps of: i) preparing a biliquid foam, ii) forming a dispersion of the biliquid foam in an aqueous solution, suspension or dispersion of a polymeric material, and iii) subjecting the dispersion to drying under conditions such that a discrete powder is formed.
Type:
Grant
Filed:
June 24, 2003
Date of Patent:
October 11, 2011
Assignee:
Drug Delivery Solutions Limited
Inventors:
Nigel Stuart Crutchley, David Charles Fletcher Gladman, Stephen John Lenon
Abstract: A polyaphron dispersion comprising an external phase and polyaphrons having an internal phase, the internal phase comprising (i) a first phase which is liquid and (ii) a second phase which is liquid or gaseous.
Abstract: An aerosol composition which is prepared from a biliquid foam, an aqueous phase and a propellant, and wherein an oil soluble functional material is incorporated into the biliquid foam during preparation to enable this material to be more readily incorporated into the composition. The aerosol composition can be contained in a pressurized aerosol can and can be a polish, an air freshener, a repellant. a pre- or post-shave preparation, a shaving preparation or a follicle softener.
Type:
Grant
Filed:
November 6, 2003
Date of Patent:
July 29, 2008
Assignee:
Drug Delivery Solutions Limited
Inventors:
Anthony Fred Mercurio, Derek Alfred Wheeler